Head and Neck Squamous Cell Carcinoma (HNSCC) Clinical Trials in the UK

Head and Neck Squamous Cell Carcinoma (HNSCC) Trials in the UK

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Site city

All 11 cities

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Active, closed

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

NCT06295731Head and Neck Squamous Cell Carcinoma (HNSCC)

Inhibrx Biosciences, Inc

Phase 2/3

410

Chelsea, Northwood, Newcastle upon Tyne, Sutton, Aberdeen, Cambridge, Manchester, Norwich

2024-05-14

Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

NCT05985655Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC), Platinum-resistant High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers (HGSOC)

Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Phase 1/2

230

Glasgow, London, Manchester, Newcastle upon Tyne, Oxford

2023-07-06

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 September 2026. https://priyalifescience.com/clinical-trials-uk/condition/head-and-neck-squamous-cell-carcinoma-hnscc

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →